Cite

HARVARD Citation

    Krishnaswamy, R. et al. (2019). Anti‐CGRP monoclonal antibodies: breakthrough in migraine therapeutics. Progress in neurology and psychiatry. 23 (3), pp. 26-33. [Online]. 
  
Back to record